Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells
- PMID: 19013148
- DOI: 10.1016/j.ejphar.2008.10.047
Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells
Abstract
The aim of the present study was to characterize the intestinal absorption of ribavirin (1-beta-d-ribofuranosyl-1, 2, 4-trizole-3-carboxamide). We evaluated the contribution of Na(+)-dependent and -independent transport to ribavirin absorption in the rat intestine using an in situ closed loop method. In addition, we performed pharmacokinetic analysis of the uptake of ribavirin in human intestinal epithelial LS180 cells, and also evaluated the effect of extracellular Na(+) concentration and an inhibitor of the Na(+)-independent equilibrative nucleoside transporter, nitrobenzylmercaptopurine ribonucleoside (NBMPR), on the uptake of ribavirin in the cells. In the presence and also absence of Na(+) in rat intestinal loops, more than 80% of the administered dose (50 microg at a concentration of 100 microg/ml=409 microM) of ribavirin was absorbed in 40 min. The absorption of ribavirin in the rat intestine was significantly reduced by coadministration of 10 mg/ml (=37.3 mM) inosine. In LS180 cells, 100 microM ribavirin was taken up time-dependently, and the influx clearance of the drug was similar to the efflux clearance. Five mM inosine and mizoribine reduced the uptake of 100 microM ribavirin in LS180 cells. The absence of extracellular Na(+) decreased the uptake of 100 microM ribavirin only weakly in the cells, whereas the uptake of 100 microM-2 mM ribavirin was markedly decreased by 100 microM NBMPR. These findings suggested that Na(+)-independent nucleoside transport contributes significantly to intestinal absorption of ribavirin at relatively high concentrations (>or=100 microM).
Similar articles
-
Membrane transport mechanisms of mizoribine in the rat intestine and human epithelial LS180 cells.Biol Pharm Bull. 2009 Apr;32(4):741-5. doi: 10.1248/bpb.32.741. Biol Pharm Bull. 2009. PMID: 19336917
-
Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.Eur J Pharmacol. 2007 Feb 14;557(1):1-8. doi: 10.1016/j.ejphar.2006.10.062. Epub 2006 Nov 3. Eur J Pharmacol. 2007. PMID: 17140564
-
Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ.Exp Physiol. 2008 Mar;93(3):325-33. doi: 10.1113/expphysiol.2007.040980. Epub 2007 Nov 26. Exp Physiol. 2008. PMID: 18039975
-
Cell entry and export of nucleoside analogues.Virus Res. 2005 Feb;107(2):151-64. doi: 10.1016/j.virusres.2004.11.005. Virus Res. 2005. PMID: 15649561 Review.
-
The clinical pharmacology of ribavirin.Semin Liver Dis. 1999;19 Suppl 1:17-24. Semin Liver Dis. 1999. PMID: 10349689 Review.
Cited by
-
Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?J Cardiovasc Pharmacol. 2015 Jun;65(6):517-21. doi: 10.1097/FJC.0000000000000194. J Cardiovasc Pharmacol. 2015. PMID: 26070128 Free PMC article. Review.
-
Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.Pharmaceuticals (Basel). 2012 Aug 10;5(8):802-36. doi: 10.3390/ph5080802. Pharmaceuticals (Basel). 2012. PMID: 24280676 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials